Science is a public good and knowledge is a source of power.

The Society of Family Planning compiles summaries of research — what the science says — on key topics to serve as a resource to members and advocates and to contribute to the goal of ensuring that the evidence base informs advocacy and decision-making. Often, but not always, Society members have conducted the research. We update these documents as new research is published.

Self-administered DMPA-SC is safe, feasible, and acceptable

(Drafted: October 10, 2023)

A high-level summary of key evidence on the safety, feasibility, and acceptability of self-administered subcutaneous depot medroxyprogesterone acetate (DMPA-SC).

Telehealth medication abortion care is safe and effective

(Drafted: September 6, 2023)

A high-level summary of key evidence on the safety and effectiveness of telehealth medication abortion care.

Misoprostol only is safe and effective

(Updated: August 21, 2023)

A high-level summary of key evidence regarding the use of misoprostol only. Clinical guidance on medication abortion, including a Society-endorsed misoprostol-only sample protocol, is also available.

Progestin-only pills are safe, effective, and appropriate for over-the-counter use

(Updated: June 30, 2023)

A high-level summary of key evidence related to over-the-counter use of progestin-only pills.

Additional resources

Abortion is essential healthcare

(Updated: November 22, 2022)

A high-level summary of what happens when abortion is out of reach.

A safe abortion that works for you

 A video that presents the several abortion options that pregnant people can safely choose from– from self-managed abortion to clinic-based care– as underscored by science. Please share with your networks using the hashtag #ScienceSays.